Pharma Focus Asia provides the senior management with the direction they need to make the strategic decisions necessary to capture market share. Our readers represent the leading players in the Asian pharma market and the top global players—your target market. And our dedicated team of researchers ensure that the distribution list is unrivalled in its quality and reach. The readers of Pharma Focus Asia have requested to receive the publication because they recognise the value of its independent reporting. Taking a closer look at the quality of writing and the journalistic integrity, it clearly makes Pharma Focus Asia a powerful prospect for readers.

Pharma Focus Asia’s circulation is spread across the following segments:

Pharma Focus Asia is published quarterly with a minimum circulation of 10,000 copies (with an estimated readership of 56,000 key decision makers. Source: Publisher's Survey) distributed throughout Asia Pacific and the Middle East to countries including: Australia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Philippines, Republic of Korea, Singapore, Taiwan, Thailand, Vietnam, UAE, Saudi Arabia, Israel and Kuwait and also Western Europe and North America.
Our readers represent the most important organisations in the Asian and global pharmaceutical market.